Karolinska Development has named Per Aniansson has its chief financial officer and investment director to replace Fredrik Järrsten.

Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

The vehicle will invest in all winners of the Venture Kick competition and will provide follow-on funding in two subsequent rounds.

Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.

Cision, already a shareholder in the social media analytics provider, is set to pay $450m to acquire it, following $63m in funding.

Midroc Europe led a round that increzased the wave energy technology developer's total equity funding to $25m.

Satt Paris-Saclay portfolio company EG 427 has collected $14m in its first funding round.

Karolinska Development has promoted general counsel Johan Dighed to deputy chief executive.

New York Digital Investment Group was among the investors in the Bitcoin payment service’s seed round, which valued it at $71m.